COVID-19 and the human body: nicotine as a “controller” of the molecular expression of ACE-2
Nicotine is a protective shield against the insurgence of severe symptoms of COVID-19. This is what emerged with the new study by CoEHAR
Gtfn 2020: Sustainability and Innovation are crucially for the future of Tobacco Harm Reduction
What are the best practises the tobacco industry should follow to achieve a sustainable change through the innovation and regulation? This was the question that this year’s Global Tobacco and Nicotine Forum, GTFN 2020, focused on
CoEHAR research set new guidelines for the dosage of nicotine in liquids
CoEHAR researchers call out the standardization of research methodologies on electronic cigarettes as a milestone for the effectiveness of the procedures to quit smoking
The new Vaping Manual between Science and Real Use
Toxicological testing, population studies, clinical trials and randomized controlled trials demonstrate the potential reductions in exposures for smokers. Unfortunately, socio-cultural and economics barriers, such as heavy taxation, misperceptions about nicotine and unsubstantiated fears of youth addiction, prevent low risk products to become accessible to all and a good choice for those who want to quit smoking.
Smoking and COVID-19: hospitalized smokers are far fewer than expected but have more severe disease
A new study published in the journal "Therapeutic Advances in Chronic Disease" provides important insight to the issue of smoking and COVID-19. The number of smokers with severe COVID-19 that requires hospitalization is by far lower than expected based on population smoking rates. The very few smokers who are eventually hospitalized have higher odds for severe disease and adverse outcome.
The Global Forum on Nicotine 2020 moves online
The organisers of the Global Forum on Nicotine (GFN), KAC Communications, are launching an online version of GFN20 which will take place on Thursday 11 and Friday 12 June following the cancellation of the face-to-face event in Warsaw due to COVID-19
We cannot talk about the correlation between smoking and COVID-19. Li Volti: “We only create confusion”
A recent study by Prof. Brake SJ studied the correlation between smoking and the angiotensin converting enzyme 2 and its implications to COVID-19. The author's hypothesis suggests an increased risk…
